Trucks, Trailers, Talent, Terminals and 2021, we are r... C. England - Dedicated East C. England is hiring Class A drivers to join our Dedicated fleet.... U. Team Drivers. HUGE. 30, 000 Sign On Bonus split with TONS of miles!. Your team can earn up to. 175, 000. or much more! Only 3 Months Experience Required! Doubles Endorsement? Make ev... Swift - Dedicated Northeast CDL A Company Truck DriverDedicated Runs. 10, 000 Transition Bonus! As Dedicated Teams CDL A Driver, you want the rewards of a successful career. Swift delivers more miles, more load... CalArk The Wheels That Move Your its start in 1975, CalArk has established itself as the industry leading, irregular route carrier that it has developed into today. We have a... USA Truck 00. COMMITTED TO A POSITIVE DRIVER EXPERIENCENEW Self Dispatch Opportunity At USA Truck! Because we're 100. committed to a positive driver experience, we're proud to reward profess... Cardinal Logistics Company Driver. REGIONAL. 75K. 85K. Curtainside NO TOUCH.
Content Harmony employs a client-focused team of people with backgrounds in content management, search marketing, software development, and online business development. The company has supported work flexibility with job openings for part-time work, flexible schedules, and remote work options. In addition to traditional employment, Content Harmony jobs have also been posted for freelance jobs in writing and software development. Visit Content Harmony's website
"We got a call from our headquarters basically telling us, 'Hey, there is this coronavirus like thing that's showing up in China', " Eckmeier said. "They had released the genomic sequence [of the virus], I mean, kind of open got a call [from headquarters]. They said, 'Hey, what do we have that could potentially combat this disease if it was to turn into a global pandemic or if it was to end up on our shores. '" Remdesivir was originally created in 2009 by Gilead Sciences, a large American biopharmaceutical company, to combat hepatitis C and respiratory syncytial virus (RSV), but it proved to be ineffective against both. With the help of the Defense Threat Reduction Agency's Joint Science and Technology Office in Fort Belvoir, Virginia, and USAMRIID on Fort Detrick, remdesivir was repurposed for use against other viruses, such as Ebola and Marburg. In 2015, preclinical trials at USAMRIID showed that remdesivir blocked Ebola in Rhesus monkeys, paving the way for it to eventually be used in human trials.